ENTITY
Bloomage Biotechnology  Lt

Bloomage Biotechnology Lt (688363 CH)

65
Analysis
Health CareChina
Bloomage Biotechnology Corporation Limited develops and manufactures medical products. The Company produces fillers, mesotherapy products, bio reactive hyaluronic acids, repair soothing skin care products, and other products. Bloomage Biotechnology supplies its products in medicine, cosmetics, food manufacturing companies, medical institutions, and other fields.
more
Refresh
bullishGiant Biogene
26 Oct 2022 21:06

Pre-IPO Giant Biogene (2367 HK) - Some Unstable Factors

Giant Biogene's marketing-driven development will lead to low margins. It takes time for recombinant collagen to replace animal-derived collagen....

Logo
135 Views
Share
bullishGiant Biogene
25 Oct 2022 23:33

Giant Biogene IPO: Valuation Insights

The China A Share peers have derated due to the sharp sell-off in the last few days. Nevertheless, Biogene is attractively valued at the IPO price...

Logo
154 Views
Share
bullishGiant Biogene
25 Oct 2022 11:17

Giant Biogene IPO - Reasonable Valuation but in Unreasonable Markets

Giant Biogene is now looking to raise around US$80m in its Hong Kong IPO, down from its earlier target of US$500m raising.

Logo
226 Views
Share
bullishGiant Biogene
23 Oct 2022 22:12

Giant Biogene IPO: Valuation First Look

Giant Biogene will launch its US$500 million HKEx IPO this week. In this note, we present our forecasts and take the first look at its potential...

Logo
270 Views
Share
bullishGiant Biogene
19 Oct 2022 09:51

Giant Biogene Pre-IPO - Thoughts on Valuation

Giant Biogene Holding (GBH HK) aims to raise around US$500m in its Hong Kong IPO. In this note, we talk about valuations.

Logo
215 Views
Share
x